Press Releases

Lexicon Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on April 27, 2020	Apr 22, 2020
Lexicon Pharmaceuticals to Host Virtual Annual Meeting of Stockholders on April 23, 2020	Apr 07, 2020
Lexicon Pharmaceuticals Provides an Update on the Sotagliflozin Type 2 Diabetes Program	Mar 19, 2020
Lexicon Pharmaceuticals Announces Additional Data on Telotristat Ethyl’s Antiproliferative Effects in Patients with Carcinoid Syndrome	Mar 13, 2020
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides a Business Update	Mar 12, 2020
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-year 2019 Financial Results Conference Call and Webcast on March 12, 2020	Mar 05, 2020
Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients with Carcinoid Syndrome	Jan 24, 2020
Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium	Jan 20, 2020
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Jan 06, 2020
Lexicon Pharmaceuticals Announces Topline Phase 3 Data for Sotagliflozin in Type 2 Diabetes	Dec 20, 2019